Outpace Bio
Jared Hammer is a skilled scientist with extensive experience in cell sciences, particularly in managing recombinant protein production and cell line generation using CRISPRi technology. Currently serving as Scientist I at Outpace Bio since November 2021, Jared's previous roles include Senior Research Associate at Outpace Bio and Associate Scientist at Bristol Myers Squibb, where responsibilities included maintaining production cell lines and performing molecular biology assays. Prior experience at Juno Therapeutics involved similar competencies within a cell sciences team. At the University of Washington's School of Medicine, Jared independently researched the mechanisms of infection of Kaposi's sarcoma-associated herpesvirus. Academic credentials include a Master of Science in Biochemistry and a Bachelor of Science in Biochemistry, both from the University of Vermont.
This person is not in any teams
Outpace Bio
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety.It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacyand safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.